Sugi Predict

Sugi Predict / Compounds / SCHEMBL29736716

SCHEMBL29736716

SCHEMBL29736716

CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ APLNR P35414 17/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30444899 0.92 APLNR (0.77) APLNR
SCHEMBL29598921 0.91 APLNR (0.78) APLNR
SCHEMBL29669783 0.91 APLNR (0.78) APLNR
SCHEMBL31281580 0.89 APLNR (0.69) APLNR
SCHEMBL30359267 0.89 APLNR (0.88) APLNR
SCHEMBL30359270 0.89 APLNR (0.88) APLNR
SCHEMBL31253160 0.89 APLNR (0.73) APLNR
SCHEMBL29413125 0.88 APLNR (0.74) APLNR
SCHEMBL30445226 0.88 APLNR (0.73) APLNR
SCHEMBL30958067 0.88 APLNR (0.69) APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119925565-A Application of polypeptide in preparation of psoriasis treatment drugs 河南大学 2025-05-06 — — CN claimed
CN-119925565-A Application of polypeptide in preparation of psoriasis treatment drugs 河南大学 2025-05-06 — — CN disclosed
WO-2024011333-A1 METHOD OF TREATING SKELETAL MUSCLE STEM CELL PATHOLOGIC DYSFUNCTION SOCPRA SCIENCES SANTÉ ET HUMAINES S.E.C. (CA) 2024-01-18 — — WO disclosed
EP-3237435-B1 METABOLICALLY STABLE APELIN ANALOGS IN THE TREATMENT OF DISEASE MEDIATED BY THE APELIN RECEPTOR INST NAT SANTE RECH MED (FR) 2023-05-24 — — EP disclosed
WO-2022138936-A1 MYELIN SHEATH REPAIR AGENT 国立研究開発法人国立精神・神経医療研究センター 2022-06-30 — — WO disclosed
Send feedback